- GBP/USD has been hovering around 1.3950 as markets are torn by mixed virus developments.
- The next dose of optimism has sterling well-positioned to gain.
- Thursday's four-hour chart is pointing to the upside.
Post-pandemic bloom or virus gloom? That is the question grappling markets as optimism about a vaccine-led recovery in the Western world contradicts horrific figures in India. Wednesday's stocks rally weighed on the safe-haven dollar while the worrying news from India is boosting the greenback.
US Treasury yields rise from a six-week low has also kept the dollar bid. Will it last? The focus may easily shift back America's economic boom, especially if US jobless claims refrain from leaping back to the previous higher. The decrease from levels above 700,000 to 576,000 last week was a welcome surprise and economists expect a consolidation of this improvement.
The market mood may improve also due to an improving virus situation in the US. After several weeks of increasing cases, the curve flattened and has begun turning down. As long as investors do not worry about slowing vaccination rates – partly due to the decision to suspend the usage of Johnson & Johnson's jabs – shares have room to rise and the dollar could fall.
On the other side of the pond, sterling is well-positioned to take advantage of such a move. The UK is on the verge of reaching 50% of its population with at least one dose of immunization while infections, hospitalizations, and deaths are all declining.
All in all, the fundamental picture remains favorable for cable bulls.
GBP/USD Technical Analysis
Pound/dollar continues benefiting from upside momentum on the four-hour chart and trades well above the 50, 100 and 200 Simple Moving Averages. Moreover, the 50 SMA crossed above the 200 SMA, a bullish development.
Some resistance awaits at the daily high of 1.3950, followed by the fresh April peak of 1.4010. It is followed only by 1.4140, significantly higher.
Support is at this week's swing low of 1.3880, followed by 1.3850 and 1.38.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.